Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate change

19 Mar 2026 07:00

RNS Number : 2295X
Elementis PLC
19 March 2026
 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 of 16 April 2014 which forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Appointment of Non-Executive Chair and Non-Executive Director

 

Elementis plc ("Elementis" or the "Group") is pleased to announce the appointment of Trudy Schoolenberg as Non-Executive Chair with effect from the end of the Annual General Meeting on 29 April 2026. Trudy will succeed John O'Higgins who announced in October 2026 that he would not stand for re-election.

Trudy has served as Non-Executive Senior Independent Director of Elementis since April 2022. She has around 35 years' experience in the chemicals, engineering and high‑performance product sectors, including ten years as a Senior Independent Director. Trudy also serves as Chair of Accsys Technologies PLC. Trudy's deep experience means she is exceptionally well placed to lead the Board of Elementis as it enters its next phase of growth. Trudy will continue as a member of the Remuneration Committee and will chair the Nomination Committee.

Christine Soden, Non-Executive Director, will be appointed as interim Senior Independent Director. Christine will continue in her current committee roles.

Elementis is also pleased to announce the appointment of Mike Humphrey as an Independent Non-Executive Director with effect from 29 April 2026, the date of its forthcoming AGM. Mike will bring significant leadership and operational experience in the specialty chemicals sector, having been Chief Executive Officer of Croda International plc from 1999 to 2011, playing a crucial role in reshaping its strategic focus on specialty markets. During Mike's tenure, Croda developed into a focused, innovation-led business with strong margins, global reach and a premium market positioning.

Trudy Schoolenberg, Chair designate and Non-Executive Director, said:

"I am delighted to be appointed Chair and look forward to working with Mike and the rest of the Board to support Luc van Ravenstein and the Leadership Team as they deliver our Elevate Elementis strategy."

Luc van Ravenstein, CEO, said:

"I would like to congratulate Trudy on her appointment as Chair. Her broad international experience, deep knowledge of the industry and respected position within Elementis make her the right leader at this important juncture for the business. I am also very pleased to welcome Mike, whose expertise will bring additional strength and depth to the Board."

There are no further disclosures required in respect of this announcement under UKLR.6.4.8.

The person responsible for the release of this announcement on behalf of Elementis plc is Hannah Constantine, Group General Counsel and Company Secretary.

Enquiries

Investors:

Hannah Constantine, Group General Counsel & Company Secretary, Elementis plc

Tel: +44 (0) 20 8148 5966

Zeeshan Maqbool, Investor Relations, Elementis plc

Tel: +44 (0) 7553 340 380

Press:

Martin Robinson/Giles Kernick, Teneo

Tel: +44 (0) 20 7353 4200

 

 

LEI: 549300LQIH685LI2ML36 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWRORNRUOAUR
Date   Source Headline
11th Jul 20255:32 pmRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20256:04 pmRNSTransaction in Own Shares
8th Jul 20255:27 pmRNSTransaction in Own Shares
7th Jul 20255:54 pmRNSTransaction in Own Shares
4th Jul 20255:30 pmRNSTransaction in Own Shares
3rd Jul 20256:05 pmRNSTransaction in Own Shares
2nd Jul 20255:49 pmRNSTransaction in Own Shares
1st Jul 20255:42 pmRNSTransaction in Own Shares
30th Jun 20256:02 pmRNSTransaction in Own Shares
27th Jun 20255:51 pmRNSTransaction in Own Shares
26th Jun 20255:55 pmRNSTransaction in Own Shares
25th Jun 20255:49 pmRNSTransaction in Own Shares
24th Jun 20255:52 pmRNSTransaction in Own Shares
23rd Jun 20255:31 pmRNSTransaction in Own Shares
20th Jun 20256:22 pmRNSTransaction in Own Shares
18th Jun 20256:06 pmRNSTransaction in Own Shares
17th Jun 20255:43 pmRNSTransaction in Own Shares
16th Jun 20256:07 pmRNSTransaction in Own Shares
13th Jun 20255:53 pmRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20255:38 pmRNSTransaction in Own Shares
10th Jun 20255:33 pmRNSTransaction in Own Shares
10th Jun 20253:49 pmRNSDirector/PDMR Shareholding
10th Jun 20253:48 pmRNSDirector/PDMR Shareholding
9th Jun 20256:19 pmRNSTransaction in Own Shares
6th Jun 20255:10 pmRNSTransaction in Own Shares
5th Jun 20255:54 pmRNSTransaction in Own Shares
4th Jun 20255:56 pmRNSTransaction in Own Shares
3rd Jun 20255:55 pmRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSCommencement of Share Buyback
27th May 20257:00 amRNSSale of Talc business and intended buyback launch
7th May 20254:55 pmRNSHolding(s) in Company
1st May 202510:20 amRNSTotal Voting Rights
29th Apr 202512:24 pmRNSResult of AGM
29th Apr 20257:00 amRNSFirst quarter trading update
25th Mar 20254:22 pmRNSAnnual Financial Report & Notice of AGM
18th Mar 20254:22 pmRNSHolding(s) in Company
18th Mar 20253:10 pmRNSAdditional Listing
13th Mar 20257:00 amRNSAppointment of new Chief Executive Officer
6th Mar 20257:00 amRNSPreliminary results year ended 31 December 2024
3rd Mar 20259:41 amRNSBlock listing Interim Review
3rd Mar 20259:31 amRNSTotal Voting Rights
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.